[1]
I. Savić i D. Oprić, „PD-1/PD-L1: A NOVEL TARGET FOR IMMUNOTHERAPY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER“, MedPodml, vol 69, izd. 2, Juni 2018, doi: 10.5937/mp69-15842.